MedTrace Logo

Treatment of Hyperuricemia in Patients With Heart Failure

NCT00422318 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2007-01-15

No results posted yet for this study

Summary

The study aims to assess (I) the contribution of UA itself to the CHF pathophysiology and (II) to test the effect of lowering UA by uricosuric treatment in CHF.

Conditions

Interventions

DRUG

Benzbromarone (drug)

Sponsors & Collaborators

  • Tottori University Hospital

    lead OTHER

Principal Investigators

  • Kazuhide Ogino, MD · Tottori University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Completion
2005-12-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00422318 on ClinicalTrials.gov